|A molecular taxonomy for urothelial carcinoma|
G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ...
Clinical cancer research 18 (12), 3377-3386, 2012
|Tertiary lymphoid structures improve immunotherapy and survival in melanoma|
R Cabrita, M Lauss, A Sanna, M Donia, MS Larsen, S Mitra, I Johansson, ...
Nature 577 (7791), 561-565, 2020
|Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma|
D Lindgren, G Sjödahl, M Lauss, J Staaf, G Chebil, K Lövgren, ...
PloS one 7 (6), e38863, 2012
|Toward a molecular pathologic classification of urothelial carcinoma|
G Sjödahl, K Lövgren, M Lauss, O Patschan, S Gudjonsson, G Chebil, ...
The American journal of pathology 183 (3), 681-691, 2013
|Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma|
M Lauss, M Donia, K Harbst, R Andersen, S Mitra, F Rosengren, M Salim, ...
Nature communications 8 (1), 1-11, 2017
|A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1|
G Sjödahl, M Lauss, S Gudjonsson, F Liedberg, C Halldén, G Chebil, ...
PloS one 6 (4), e18583, 2011
|A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma|
O Patschan, G Sjödahl, G Chebil, K Lövgren, M Lauss, S Gudjonsson, ...
European urology 68 (5), 824-832, 2015
|Molecular profiling reveals low-and high-grade forms of primary melanoma|
K Harbst, J Staaf, M Lauss, A Karlsson, A Måsbäck, I Johansson, ...
Clinical cancer research 18 (15), 4026-4036, 2012
|Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy|
H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ...
Oncotarget 6 (14), 12297, 2015
|Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker|
I Johansson, C Nilsson, P Berglund, M Lauss, M Ringnér, H Olsson, ...
Breast Cancer Research 14 (1), 1-15, 2012
|Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma|
K Harbst, M Lauss, H Cirenajwis, K Isaksson, F Rosengren, T Törngren, ...
Cancer research 76 (16), 4765-4774, 2016
|Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors|
G Sjödahl, K Lövgren, M Lauss, G Chebil, O Patschan, S Gudjonsson, ...
Urologic Oncology: Seminars and Original Investigations 32 (6), 791-797, 2014
|Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome|
A Karlsson, M Jönsson, M Lauss, H Brunnström, P Jönsson, Å Borg, ...
Clinical Cancer Research 20 (23), 6127-6140, 2014
|NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics|
H Cirenajwis, M Lauss, H Ekedahl, T Törngren, A Kvist, LH Saal, H Olsson, ...
Molecular oncology 11 (4), 438-451, 2017
|Molecular and genetic diversity in the metastatic process of melanoma|
K Harbst, M Lauss, H Cirenajwis, C Winter, J Howlin, T Törngren, A Kvist, ...
The Journal of pathology 233 (1), 39-50, 2014
|Efficient arsenic metabolism—the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT|
KS Engström, MB Hossain, M Lauss, S Ahmed, R Raqib, M Vahter, ...
PloS one 8 (1), e53732, 2013
|An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells|
K Holm, J Staaf, M Lauss, M Aine, D Lindgren, PO Bendahl, ...
Breast Cancer Research 18 (1), 1-20, 2016
|Monitoring of technical variation in quantitative high-throughput datasets|
M Lauss, I Visne, A Kriegner, M Ringnér, G Jönsson, M Höglund
Cancer informatics 12, CIN. S12862, 2013
|DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status|
M Lauss, M Aine, G Sjödahl, S Veerla, O Patschan, S Gudjonsson, ...
Epigenetics 7 (8), 858-867, 2012
|Promoter methylation of PTEN is a significant prognostic factor in melanoma survival|
MR Roh, S Gupta, KH Park, KY Chung, M Lauss, KT Flaherty, G Jönsson, ...
Journal of Investigative Dermatology 136 (5), 1002-1011, 2016